Burzynski cancer treatment.

Stanislaw Burzynski, MD, PhD, discovered antineoplastons (peptides that commonly appear in healthy people) while researching cancer in Poland in the 1960s. Because antineoplastons are rare or non-existent in people with cancer, Dr. Burzynski hypothesized that the peptides might be a defense mechanism. Eventually, he discovered that antineoplastons inhibit cancer cell division. Dr. Burzynski isolated the peptides from blood and urine and gave them to patients intravenously. A patient's odds of recovering from cancer increased as the numbers of antineoplastons in their body rose. Dr. Burzynski now uses antineoplastons that he has synthesized in a lab.

For years, the Food and Drug Administration (FDA) and federal government have tried to discredit Dr. Burzynski's work and keep him from treating patients. "They've raided his office, placed restrictions on patient enrollment, and subjected him to grand juries," Dr. Julian Whitaker says in his newsletter. A grand jury issued a 75-count indictment against Dr. Burzynski and his clinic in 1995. The charges included 40 counts of interstate delivery of an unapproved drug, 34 counts of mail fraud for mailing claims to insurers, and one count of contempt for violating a 1984 federal court order that prevented him from shipping his drug out of state. Dr. Burzynski was acquitted of all charges. Even so, the legal expense of fighting the government is so overwhelming that doctors who buck the system find themselves ruined financially and have to close their clinics. In Dr. Burzynski's case, public support from Dr. Julian Whitaker in his newsletter, Health and Healing, prompted his subscribers to donate over $700,000 to the Burzynski Legal Defense Fund.

Only patients who take part in FDA-controlled clinical trials can receive IV antineoplastons at the Burzynski Clinic in Houston, Texas. Nearly 60 such trials are recruiting patients or are already in-process, according to www.clinicaltrials.gov. People who do not want to take part in a study receive individualized treatment that includes customized nutrition, targeted gene therapies, and other non~ and low-toxic treatments. For more information about the clinic and its success rates for various cancers, visit www.burzynskiclinic.com or www.burzynskipatientgroup. org or call 713-335-5697.

Doctor cleared in trial on unapproved drugs. The New York Times. May 28, 1997.

Available at: http://query,nytimes.com/gst/fullpage.htmlrres = 9BDDEED7143AF93B A15756C096195. Accessed May 22, 2008.

Whitaker J. Thirty years of saving lives. Health & Heating. February 2008;18(2):1-4,6.